EMEA-000093-PIP01-07-M01

Key facts

Active substance
Sotrastaurin acetate
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/155/2011
PIP number
EMEA-000093-PIP01-07-M01
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of chronic plaque psoriasis
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Ltd
paediatric.enquiries@novartis.com
Switzerland
Phone: +41 61 324 1111
Fax: +41 61 324 8001
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating